Global Immunology Drug Market Growth 2025-2031
The global Immunology Drug market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
The immune system is an assembly of structures and processes inside the body to protect against possibly damaging foreign bodies and diseases. It identifies various threats like bacteria, viruses, and parasites and distinguishes them from body's healthy tissues. When the immune system weakness and lose the capability to detect and destroy the abnormal cells or body attacks and damages its tissues lead to diseases like cancer and autoimmune diseases. Immunotherapy is a process which includes the treatment by inducing, enhancing or suppressing an immune system to fight against the diseases.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the ?Immunology Drug Industry Forecast? looks at past sales and reviews total world Immunology Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Immunology Drug sales for 2025 through 2031. With Immunology Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Immunology Drug industry.
This Insight Report provides a comprehensive analysis of the global Immunology Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Immunology Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Immunology Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Immunology Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Immunology Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Immunology Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Immunology Drug market?
What factors are driving Immunology Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Immunology Drug market opportunities vary by end market size?
How does Immunology Drug break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
The immune system is an assembly of structures and processes inside the body to protect against possibly damaging foreign bodies and diseases. It identifies various threats like bacteria, viruses, and parasites and distinguishes them from body's healthy tissues. When the immune system weakness and lose the capability to detect and destroy the abnormal cells or body attacks and damages its tissues lead to diseases like cancer and autoimmune diseases. Immunotherapy is a process which includes the treatment by inducing, enhancing or suppressing an immune system to fight against the diseases.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the ?Immunology Drug Industry Forecast? looks at past sales and reviews total world Immunology Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Immunology Drug sales for 2025 through 2031. With Immunology Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Immunology Drug industry.
This Insight Report provides a comprehensive analysis of the global Immunology Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Immunology Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Immunology Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Immunology Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Immunology Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Immunology Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Monoclonal Antibodies (mAb)
- Antibody Drug Conjugates
- Immunosuppressive medication
- Others
- Hospitals
- Clinics
- Cancer Research Centers and Institutes
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Abbott Laboratories
- Active Biotech
- Eli Lilly and Company
- Autoimmune Inc.
- Pfizer
- GlaxoSmithKline plc
- Seattle Genetics
- Genentech
- F. Hoffmann-La Roche Ltd.
- Eisai Co.
- Bayer AG
- Sanofi Aventis LLC.
What is the 10-year outlook for the global Immunology Drug market?
What factors are driving Immunology Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Immunology Drug market opportunities vary by end market size?
How does Immunology Drug break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Immunology Drug Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Immunology Drug by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Immunology Drug by Country/Region, 2020, 2024 & 2031
2.2 Immunology Drug Segment by Type
2.2.1 Monoclonal Antibodies (mAb)
2.2.2 Antibody Drug Conjugates
2.2.3 Immunosuppressive medication
2.2.4 Others
2.3 Immunology Drug Sales by Type
2.3.1 Global Immunology Drug Sales Market Share by Type (2020-2025)
2.3.2 Global Immunology Drug Revenue and Market Share by Type (2020-2025)
2.3.3 Global Immunology Drug Sale Price by Type (2020-2025)
2.4 Immunology Drug Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Cancer Research Centers and Institutes
2.5 Immunology Drug Sales by Application
2.5.1 Global Immunology Drug Sale Market Share by Application (2020-2025)
2.5.2 Global Immunology Drug Revenue and Market Share by Application (2020-2025)
2.5.3 Global Immunology Drug Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Immunology Drug Breakdown Data by Company
3.1.1 Global Immunology Drug Annual Sales by Company (2020-2025)
3.1.2 Global Immunology Drug Sales Market Share by Company (2020-2025)
3.2 Global Immunology Drug Annual Revenue by Company (2020-2025)
3.2.1 Global Immunology Drug Revenue by Company (2020-2025)
3.2.2 Global Immunology Drug Revenue Market Share by Company (2020-2025)
3.3 Global Immunology Drug Sale Price by Company
3.4 Key Manufacturers Immunology Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Immunology Drug Product Location Distribution
3.4.2 Players Immunology Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR IMMUNOLOGY DRUG BY GEOGRAPHIC REGION
4.1 World Historic Immunology Drug Market Size by Geographic Region (2020-2025)
4.1.1 Global Immunology Drug Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Immunology Drug Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Immunology Drug Market Size by Country/Region (2020-2025)
4.2.1 Global Immunology Drug Annual Sales by Country/Region (2020-2025)
4.2.2 Global Immunology Drug Annual Revenue by Country/Region (2020-2025)
4.3 Americas Immunology Drug Sales Growth
4.4 APAC Immunology Drug Sales Growth
4.5 Europe Immunology Drug Sales Growth
4.6 Middle East & Africa Immunology Drug Sales Growth
5 AMERICAS
5.1 Americas Immunology Drug Sales by Country
5.1.1 Americas Immunology Drug Sales by Country (2020-2025)
5.1.2 Americas Immunology Drug Revenue by Country (2020-2025)
5.2 Americas Immunology Drug Sales by Type (2020-2025)
5.3 Americas Immunology Drug Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Immunology Drug Sales by Region
6.1.1 APAC Immunology Drug Sales by Region (2020-2025)
6.1.2 APAC Immunology Drug Revenue by Region (2020-2025)
6.2 APAC Immunology Drug Sales by Type (2020-2025)
6.3 APAC Immunology Drug Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Immunology Drug by Country
7.1.1 Europe Immunology Drug Sales by Country (2020-2025)
7.1.2 Europe Immunology Drug Revenue by Country (2020-2025)
7.2 Europe Immunology Drug Sales by Type (2020-2025)
7.3 Europe Immunology Drug Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Immunology Drug by Country
8.1.1 Middle East & Africa Immunology Drug Sales by Country (2020-2025)
8.1.2 Middle East & Africa Immunology Drug Revenue by Country (2020-2025)
8.2 Middle East & Africa Immunology Drug Sales by Type (2020-2025)
8.3 Middle East & Africa Immunology Drug Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Immunology Drug
10.3 Manufacturing Process Analysis of Immunology Drug
10.4 Industry Chain Structure of Immunology Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Immunology Drug Distributors
11.3 Immunology Drug Customer
12 WORLD FORECAST REVIEW FOR IMMUNOLOGY DRUG BY GEOGRAPHIC REGION
12.1 Global Immunology Drug Market Size Forecast by Region
12.1.1 Global Immunology Drug Forecast by Region (2026-2031)
12.1.2 Global Immunology Drug Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Immunology Drug Forecast by Type (2026-2031)
12.7 Global Immunology Drug Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Information
13.1.2 Abbott Laboratories Immunology Drug Product Portfolios and Specifications
13.1.3 Abbott Laboratories Immunology Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Abbott Laboratories Main Business Overview
13.1.5 Abbott Laboratories Latest Developments
13.2 Active Biotech
13.2.1 Active Biotech Company Information
13.2.2 Active Biotech Immunology Drug Product Portfolios and Specifications
13.2.3 Active Biotech Immunology Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Active Biotech Main Business Overview
13.2.5 Active Biotech Latest Developments
13.3 Eli Lilly and Company
13.3.1 Eli Lilly and Company Company Information
13.3.2 Eli Lilly and Company Immunology Drug Product Portfolios and Specifications
13.3.3 Eli Lilly and Company Immunology Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Eli Lilly and Company Main Business Overview
13.3.5 Eli Lilly and Company Latest Developments
13.4 Autoimmune Inc.
13.4.1 Autoimmune Inc. Company Information
13.4.2 Autoimmune Inc. Immunology Drug Product Portfolios and Specifications
13.4.3 Autoimmune Inc. Immunology Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Autoimmune Inc. Main Business Overview
13.4.5 Autoimmune Inc. Latest Developments
13.5 Pfizer
13.5.1 Pfizer Company Information
13.5.2 Pfizer Immunology Drug Product Portfolios and Specifications
13.5.3 Pfizer Immunology Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Pfizer Main Business Overview
13.5.5 Pfizer Latest Developments
13.6 GlaxoSmithKline plc
13.6.1 GlaxoSmithKline plc Company Information
13.6.2 GlaxoSmithKline plc Immunology Drug Product Portfolios and Specifications
13.6.3 GlaxoSmithKline plc Immunology Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 GlaxoSmithKline plc Main Business Overview
13.6.5 GlaxoSmithKline plc Latest Developments
13.7 Seattle Genetics
13.7.1 Seattle Genetics Company Information
13.7.2 Seattle Genetics Immunology Drug Product Portfolios and Specifications
13.7.3 Seattle Genetics Immunology Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Seattle Genetics Main Business Overview
13.7.5 Seattle Genetics Latest Developments
13.8 Genentech
13.8.1 Genentech Company Information
13.8.2 Genentech Immunology Drug Product Portfolios and Specifications
13.8.3 Genentech Immunology Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Genentech Main Business Overview
13.8.5 Genentech Latest Developments
13.9 F. Hoffmann-La Roche Ltd.
13.9.1 F. Hoffmann-La Roche Ltd. Company Information
13.9.2 F. Hoffmann-La Roche Ltd. Immunology Drug Product Portfolios and Specifications
13.9.3 F. Hoffmann-La Roche Ltd. Immunology Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 F. Hoffmann-La Roche Ltd. Main Business Overview
13.9.5 F. Hoffmann-La Roche Ltd. Latest Developments
13.10 Eisai Co.
13.10.1 Eisai Co. Company Information
13.10.2 Eisai Co. Immunology Drug Product Portfolios and Specifications
13.10.3 Eisai Co. Immunology Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Eisai Co. Main Business Overview
13.10.5 Eisai Co. Latest Developments
13.11 Bayer AG
13.11.1 Bayer AG Company Information
13.11.2 Bayer AG Immunology Drug Product Portfolios and Specifications
13.11.3 Bayer AG Immunology Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Bayer AG Main Business Overview
13.11.5 Bayer AG Latest Developments
13.12 Sanofi Aventis LLC.
13.12.1 Sanofi Aventis LLC. Company Information
13.12.2 Sanofi Aventis LLC. Immunology Drug Product Portfolios and Specifications
13.12.3 Sanofi Aventis LLC. Immunology Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Sanofi Aventis LLC. Main Business Overview
13.12.5 Sanofi Aventis LLC. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Immunology Drug Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Immunology Drug by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Immunology Drug by Country/Region, 2020, 2024 & 2031
2.2 Immunology Drug Segment by Type
2.2.1 Monoclonal Antibodies (mAb)
2.2.2 Antibody Drug Conjugates
2.2.3 Immunosuppressive medication
2.2.4 Others
2.3 Immunology Drug Sales by Type
2.3.1 Global Immunology Drug Sales Market Share by Type (2020-2025)
2.3.2 Global Immunology Drug Revenue and Market Share by Type (2020-2025)
2.3.3 Global Immunology Drug Sale Price by Type (2020-2025)
2.4 Immunology Drug Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Cancer Research Centers and Institutes
2.5 Immunology Drug Sales by Application
2.5.1 Global Immunology Drug Sale Market Share by Application (2020-2025)
2.5.2 Global Immunology Drug Revenue and Market Share by Application (2020-2025)
2.5.3 Global Immunology Drug Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Immunology Drug Breakdown Data by Company
3.1.1 Global Immunology Drug Annual Sales by Company (2020-2025)
3.1.2 Global Immunology Drug Sales Market Share by Company (2020-2025)
3.2 Global Immunology Drug Annual Revenue by Company (2020-2025)
3.2.1 Global Immunology Drug Revenue by Company (2020-2025)
3.2.2 Global Immunology Drug Revenue Market Share by Company (2020-2025)
3.3 Global Immunology Drug Sale Price by Company
3.4 Key Manufacturers Immunology Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Immunology Drug Product Location Distribution
3.4.2 Players Immunology Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR IMMUNOLOGY DRUG BY GEOGRAPHIC REGION
4.1 World Historic Immunology Drug Market Size by Geographic Region (2020-2025)
4.1.1 Global Immunology Drug Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Immunology Drug Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Immunology Drug Market Size by Country/Region (2020-2025)
4.2.1 Global Immunology Drug Annual Sales by Country/Region (2020-2025)
4.2.2 Global Immunology Drug Annual Revenue by Country/Region (2020-2025)
4.3 Americas Immunology Drug Sales Growth
4.4 APAC Immunology Drug Sales Growth
4.5 Europe Immunology Drug Sales Growth
4.6 Middle East & Africa Immunology Drug Sales Growth
5 AMERICAS
5.1 Americas Immunology Drug Sales by Country
5.1.1 Americas Immunology Drug Sales by Country (2020-2025)
5.1.2 Americas Immunology Drug Revenue by Country (2020-2025)
5.2 Americas Immunology Drug Sales by Type (2020-2025)
5.3 Americas Immunology Drug Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Immunology Drug Sales by Region
6.1.1 APAC Immunology Drug Sales by Region (2020-2025)
6.1.2 APAC Immunology Drug Revenue by Region (2020-2025)
6.2 APAC Immunology Drug Sales by Type (2020-2025)
6.3 APAC Immunology Drug Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Immunology Drug by Country
7.1.1 Europe Immunology Drug Sales by Country (2020-2025)
7.1.2 Europe Immunology Drug Revenue by Country (2020-2025)
7.2 Europe Immunology Drug Sales by Type (2020-2025)
7.3 Europe Immunology Drug Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Immunology Drug by Country
8.1.1 Middle East & Africa Immunology Drug Sales by Country (2020-2025)
8.1.2 Middle East & Africa Immunology Drug Revenue by Country (2020-2025)
8.2 Middle East & Africa Immunology Drug Sales by Type (2020-2025)
8.3 Middle East & Africa Immunology Drug Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Immunology Drug
10.3 Manufacturing Process Analysis of Immunology Drug
10.4 Industry Chain Structure of Immunology Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Immunology Drug Distributors
11.3 Immunology Drug Customer
12 WORLD FORECAST REVIEW FOR IMMUNOLOGY DRUG BY GEOGRAPHIC REGION
12.1 Global Immunology Drug Market Size Forecast by Region
12.1.1 Global Immunology Drug Forecast by Region (2026-2031)
12.1.2 Global Immunology Drug Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Immunology Drug Forecast by Type (2026-2031)
12.7 Global Immunology Drug Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Information
13.1.2 Abbott Laboratories Immunology Drug Product Portfolios and Specifications
13.1.3 Abbott Laboratories Immunology Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Abbott Laboratories Main Business Overview
13.1.5 Abbott Laboratories Latest Developments
13.2 Active Biotech
13.2.1 Active Biotech Company Information
13.2.2 Active Biotech Immunology Drug Product Portfolios and Specifications
13.2.3 Active Biotech Immunology Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Active Biotech Main Business Overview
13.2.5 Active Biotech Latest Developments
13.3 Eli Lilly and Company
13.3.1 Eli Lilly and Company Company Information
13.3.2 Eli Lilly and Company Immunology Drug Product Portfolios and Specifications
13.3.3 Eli Lilly and Company Immunology Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Eli Lilly and Company Main Business Overview
13.3.5 Eli Lilly and Company Latest Developments
13.4 Autoimmune Inc.
13.4.1 Autoimmune Inc. Company Information
13.4.2 Autoimmune Inc. Immunology Drug Product Portfolios and Specifications
13.4.3 Autoimmune Inc. Immunology Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Autoimmune Inc. Main Business Overview
13.4.5 Autoimmune Inc. Latest Developments
13.5 Pfizer
13.5.1 Pfizer Company Information
13.5.2 Pfizer Immunology Drug Product Portfolios and Specifications
13.5.3 Pfizer Immunology Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Pfizer Main Business Overview
13.5.5 Pfizer Latest Developments
13.6 GlaxoSmithKline plc
13.6.1 GlaxoSmithKline plc Company Information
13.6.2 GlaxoSmithKline plc Immunology Drug Product Portfolios and Specifications
13.6.3 GlaxoSmithKline plc Immunology Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 GlaxoSmithKline plc Main Business Overview
13.6.5 GlaxoSmithKline plc Latest Developments
13.7 Seattle Genetics
13.7.1 Seattle Genetics Company Information
13.7.2 Seattle Genetics Immunology Drug Product Portfolios and Specifications
13.7.3 Seattle Genetics Immunology Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Seattle Genetics Main Business Overview
13.7.5 Seattle Genetics Latest Developments
13.8 Genentech
13.8.1 Genentech Company Information
13.8.2 Genentech Immunology Drug Product Portfolios and Specifications
13.8.3 Genentech Immunology Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Genentech Main Business Overview
13.8.5 Genentech Latest Developments
13.9 F. Hoffmann-La Roche Ltd.
13.9.1 F. Hoffmann-La Roche Ltd. Company Information
13.9.2 F. Hoffmann-La Roche Ltd. Immunology Drug Product Portfolios and Specifications
13.9.3 F. Hoffmann-La Roche Ltd. Immunology Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 F. Hoffmann-La Roche Ltd. Main Business Overview
13.9.5 F. Hoffmann-La Roche Ltd. Latest Developments
13.10 Eisai Co.
13.10.1 Eisai Co. Company Information
13.10.2 Eisai Co. Immunology Drug Product Portfolios and Specifications
13.10.3 Eisai Co. Immunology Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Eisai Co. Main Business Overview
13.10.5 Eisai Co. Latest Developments
13.11 Bayer AG
13.11.1 Bayer AG Company Information
13.11.2 Bayer AG Immunology Drug Product Portfolios and Specifications
13.11.3 Bayer AG Immunology Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Bayer AG Main Business Overview
13.11.5 Bayer AG Latest Developments
13.12 Sanofi Aventis LLC.
13.12.1 Sanofi Aventis LLC. Company Information
13.12.2 Sanofi Aventis LLC. Immunology Drug Product Portfolios and Specifications
13.12.3 Sanofi Aventis LLC. Immunology Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Sanofi Aventis LLC. Main Business Overview
13.12.5 Sanofi Aventis LLC. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Immunology Drug Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Immunology Drug Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Monoclonal Antibodies (mAb)
Table 4. Major Players of Antibody Drug Conjugates
Table 5. Major Players of Immunosuppressive medication
Table 6. Major Players of Others
Table 7. Global Immunology Drug Sales by Type (2020-2025) & (K Units)
Table 8. Global Immunology Drug Sales Market Share by Type (2020-2025)
Table 9. Global Immunology Drug Revenue by Type (2020-2025) & ($ million)
Table 10. Global Immunology Drug Revenue Market Share by Type (2020-2025)
Table 11. Global Immunology Drug Sale Price by Type (2020-2025) & (USD/Unit)
Table 12. Global Immunology Drug Sale by Application (2020-2025) & (K Units)
Table 13. Global Immunology Drug Sale Market Share by Application (2020-2025)
Table 14. Global Immunology Drug Revenue by Application (2020-2025) & ($ million)
Table 15. Global Immunology Drug Revenue Market Share by Application (2020-2025)
Table 16. Global Immunology Drug Sale Price by Application (2020-2025) & (USD/Unit)
Table 17. Global Immunology Drug Sales by Company (2020-2025) & (K Units)
Table 18. Global Immunology Drug Sales Market Share by Company (2020-2025)
Table 19. Global Immunology Drug Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Immunology Drug Revenue Market Share by Company (2020-2025)
Table 21. Global Immunology Drug Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key Manufacturers Immunology Drug Producing Area Distribution and Sales Area
Table 23. Players Immunology Drug Products Offered
Table 24. Immunology Drug Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Immunology Drug Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Immunology Drug Sales Market Share Geographic Region (2020-2025)
Table 29. Global Immunology Drug Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Immunology Drug Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Immunology Drug Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Immunology Drug Sales Market Share by Country/Region (2020-2025)
Table 33. Global Immunology Drug Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Immunology Drug Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Immunology Drug Sales by Country (2020-2025) & (K Units)
Table 36. Americas Immunology Drug Sales Market Share by Country (2020-2025)
Table 37. Americas Immunology Drug Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Immunology Drug Sales by Type (2020-2025) & (K Units)
Table 39. Americas Immunology Drug Sales by Application (2020-2025) & (K Units)
Table 40. APAC Immunology Drug Sales by Region (2020-2025) & (K Units)
Table 41. APAC Immunology Drug Sales Market Share by Region (2020-2025)
Table 42. APAC Immunology Drug Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Immunology Drug Sales by Type (2020-2025) & (K Units)
Table 44. APAC Immunology Drug Sales by Application (2020-2025) & (K Units)
Table 45. Europe Immunology Drug Sales by Country (2020-2025) & (K Units)
Table 46. Europe Immunology Drug Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Immunology Drug Sales by Type (2020-2025) & (K Units)
Table 48. Europe Immunology Drug Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & Africa Immunology Drug Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Immunology Drug Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Immunology Drug Sales by Type (2020-2025) & (K Units)
Table 52. Middle East & Africa Immunology Drug Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Immunology Drug
Table 54. Key Market Challenges & Risks of Immunology Drug
Table 55. Key Industry Trends of Immunology Drug
Table 56. Immunology Drug Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Immunology Drug Distributors List
Table 59. Immunology Drug Customer List
Table 60. Global Immunology Drug Sales Forecast by Region (2026-2031) & (K Units)
Table 61. Global Immunology Drug Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Immunology Drug Sales Forecast by Country (2026-2031) & (K Units)
Table 63. Americas Immunology Drug Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Immunology Drug Sales Forecast by Region (2026-2031) & (K Units)
Table 65. APAC Immunology Drug Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Immunology Drug Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Europe Immunology Drug Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Immunology Drug Sales Forecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Immunology Drug Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Immunology Drug Sales Forecast by Type (2026-2031) & (K Units)
Table 71. Global Immunology Drug Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Immunology Drug Sales Forecast by Application (2026-2031) & (K Units)
Table 73. Global Immunology Drug Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. Abbott Laboratories Basic Information, Immunology Drug Manufacturing Base, Sales Area and Its Competitors
Table 75. Abbott Laboratories Immunology Drug Product Portfolios and Specifications
Table 76. Abbott Laboratories Immunology Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Abbott Laboratories Main Business
Table 78. Abbott Laboratories Latest Developments
Table 79. Active Biotech Basic Information, Immunology Drug Manufacturing Base, Sales Area and Its Competitors
Table 80. Active Biotech Immunology Drug Product Portfolios and Specifications
Table 81. Active Biotech Immunology Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Active Biotech Main Business
Table 83. Active Biotech Latest Developments
Table 84. Eli Lilly and Company Basic Information, Immunology Drug Manufacturing Base, Sales Area and Its Competitors
Table 85. Eli Lilly and Company Immunology Drug Product Portfolios and Specifications
Table 86. Eli Lilly and Company Immunology Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Eli Lilly and Company Main Business
Table 88. Eli Lilly and Company Latest Developments
Table 89. Autoimmune Inc. Basic Information, Immunology Drug Manufacturing Base, Sales Area and Its Competitors
Table 90. Autoimmune Inc. Immunology Drug Product Portfolios and Specifications
Table 91. Autoimmune Inc. Immunology Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Autoimmune Inc. Main Business
Table 93. Autoimmune Inc. Latest Developments
Table 94. Pfizer Basic Information, Immunology Drug Manufacturing Base, Sales Area and Its Competitors
Table 95. Pfizer Immunology Drug Product Portfolios and Specifications
Table 96. Pfizer Immunology Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Pfizer Main Business
Table 98. Pfizer Latest Developments
Table 99. GlaxoSmithKline plc Basic Information, Immunology Drug Manufacturing Base, Sales Area and Its Competitors
Table 100. GlaxoSmithKline plc Immunology Drug Product Portfolios and Specifications
Table 101. GlaxoSmithKline plc Immunology Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. GlaxoSmithKline plc Main Business
Table 103. GlaxoSmithKline plc Latest Developments
Table 104. Seattle Genetics Basic Information, Immunology Drug Manufacturing Base, Sales Area and Its Competitors
Table 105. Seattle Genetics Immunology Drug Product Portfolios and Specifications
Table 106. Seattle Genetics Immunology Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Seattle Genetics Main Business
Table 108. Seattle Genetics Latest Developments
Table 109. Genentech Basic Information, Immunology Drug Manufacturing Base, Sales Area and Its Competitors
Table 110. Genentech Immunology Drug Product Portfolios and Specifications
Table 111. Genentech Immunology Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Genentech Main Business
Table 113. Genentech Latest Developments
Table 114. F. Hoffmann-La Roche Ltd. Basic Information, Immunology Drug Manufacturing Base, Sales Area and Its Competitors
Table 115. F. Hoffmann-La Roche Ltd. Immunology Drug Product Portfolios and Specifications
Table 116. F. Hoffmann-La Roche Ltd. Immunology Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. F. Hoffmann-La Roche Ltd. Main Business
Table 118. F. Hoffmann-La Roche Ltd. Latest Developments
Table 119. Eisai Co. Basic Information, Immunology Drug Manufacturing Base, Sales Area and Its Competitors
Table 120. Eisai Co. Immunology Drug Product Portfolios and Specifications
Table 121. Eisai Co. Immunology Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Eisai Co. Main Business
Table 123. Eisai Co. Latest Developments
Table 124. Bayer AG Basic Information, Immunology Drug Manufacturing Base, Sales Area and Its Competitors
Table 125. Bayer AG Immunology Drug Product Portfolios and Specifications
Table 126. Bayer AG Immunology Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Bayer AG Main Business
Table 128. Bayer AG Latest Developments
Table 129. Sanofi Aventis LLC. Basic Information, Immunology Drug Manufacturing Base, Sales Area and Its Competitors
Table 130. Sanofi Aventis LLC. Immunology Drug Product Portfolios and Specifications
Table 131. Sanofi Aventis LLC. Immunology Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Sanofi Aventis LLC. Main Business
Table 133. Sanofi Aventis LLC. Latest Developments
Table 1. Immunology Drug Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Immunology Drug Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Monoclonal Antibodies (mAb)
Table 4. Major Players of Antibody Drug Conjugates
Table 5. Major Players of Immunosuppressive medication
Table 6. Major Players of Others
Table 7. Global Immunology Drug Sales by Type (2020-2025) & (K Units)
Table 8. Global Immunology Drug Sales Market Share by Type (2020-2025)
Table 9. Global Immunology Drug Revenue by Type (2020-2025) & ($ million)
Table 10. Global Immunology Drug Revenue Market Share by Type (2020-2025)
Table 11. Global Immunology Drug Sale Price by Type (2020-2025) & (USD/Unit)
Table 12. Global Immunology Drug Sale by Application (2020-2025) & (K Units)
Table 13. Global Immunology Drug Sale Market Share by Application (2020-2025)
Table 14. Global Immunology Drug Revenue by Application (2020-2025) & ($ million)
Table 15. Global Immunology Drug Revenue Market Share by Application (2020-2025)
Table 16. Global Immunology Drug Sale Price by Application (2020-2025) & (USD/Unit)
Table 17. Global Immunology Drug Sales by Company (2020-2025) & (K Units)
Table 18. Global Immunology Drug Sales Market Share by Company (2020-2025)
Table 19. Global Immunology Drug Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Immunology Drug Revenue Market Share by Company (2020-2025)
Table 21. Global Immunology Drug Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key Manufacturers Immunology Drug Producing Area Distribution and Sales Area
Table 23. Players Immunology Drug Products Offered
Table 24. Immunology Drug Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Immunology Drug Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Immunology Drug Sales Market Share Geographic Region (2020-2025)
Table 29. Global Immunology Drug Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Immunology Drug Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Immunology Drug Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Immunology Drug Sales Market Share by Country/Region (2020-2025)
Table 33. Global Immunology Drug Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Immunology Drug Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Immunology Drug Sales by Country (2020-2025) & (K Units)
Table 36. Americas Immunology Drug Sales Market Share by Country (2020-2025)
Table 37. Americas Immunology Drug Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Immunology Drug Sales by Type (2020-2025) & (K Units)
Table 39. Americas Immunology Drug Sales by Application (2020-2025) & (K Units)
Table 40. APAC Immunology Drug Sales by Region (2020-2025) & (K Units)
Table 41. APAC Immunology Drug Sales Market Share by Region (2020-2025)
Table 42. APAC Immunology Drug Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Immunology Drug Sales by Type (2020-2025) & (K Units)
Table 44. APAC Immunology Drug Sales by Application (2020-2025) & (K Units)
Table 45. Europe Immunology Drug Sales by Country (2020-2025) & (K Units)
Table 46. Europe Immunology Drug Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Immunology Drug Sales by Type (2020-2025) & (K Units)
Table 48. Europe Immunology Drug Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & Africa Immunology Drug Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Immunology Drug Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Immunology Drug Sales by Type (2020-2025) & (K Units)
Table 52. Middle East & Africa Immunology Drug Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Immunology Drug
Table 54. Key Market Challenges & Risks of Immunology Drug
Table 55. Key Industry Trends of Immunology Drug
Table 56. Immunology Drug Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Immunology Drug Distributors List
Table 59. Immunology Drug Customer List
Table 60. Global Immunology Drug Sales Forecast by Region (2026-2031) & (K Units)
Table 61. Global Immunology Drug Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Immunology Drug Sales Forecast by Country (2026-2031) & (K Units)
Table 63. Americas Immunology Drug Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Immunology Drug Sales Forecast by Region (2026-2031) & (K Units)
Table 65. APAC Immunology Drug Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Immunology Drug Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Europe Immunology Drug Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Immunology Drug Sales Forecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Immunology Drug Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Immunology Drug Sales Forecast by Type (2026-2031) & (K Units)
Table 71. Global Immunology Drug Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Immunology Drug Sales Forecast by Application (2026-2031) & (K Units)
Table 73. Global Immunology Drug Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. Abbott Laboratories Basic Information, Immunology Drug Manufacturing Base, Sales Area and Its Competitors
Table 75. Abbott Laboratories Immunology Drug Product Portfolios and Specifications
Table 76. Abbott Laboratories Immunology Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Abbott Laboratories Main Business
Table 78. Abbott Laboratories Latest Developments
Table 79. Active Biotech Basic Information, Immunology Drug Manufacturing Base, Sales Area and Its Competitors
Table 80. Active Biotech Immunology Drug Product Portfolios and Specifications
Table 81. Active Biotech Immunology Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Active Biotech Main Business
Table 83. Active Biotech Latest Developments
Table 84. Eli Lilly and Company Basic Information, Immunology Drug Manufacturing Base, Sales Area and Its Competitors
Table 85. Eli Lilly and Company Immunology Drug Product Portfolios and Specifications
Table 86. Eli Lilly and Company Immunology Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Eli Lilly and Company Main Business
Table 88. Eli Lilly and Company Latest Developments
Table 89. Autoimmune Inc. Basic Information, Immunology Drug Manufacturing Base, Sales Area and Its Competitors
Table 90. Autoimmune Inc. Immunology Drug Product Portfolios and Specifications
Table 91. Autoimmune Inc. Immunology Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Autoimmune Inc. Main Business
Table 93. Autoimmune Inc. Latest Developments
Table 94. Pfizer Basic Information, Immunology Drug Manufacturing Base, Sales Area and Its Competitors
Table 95. Pfizer Immunology Drug Product Portfolios and Specifications
Table 96. Pfizer Immunology Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Pfizer Main Business
Table 98. Pfizer Latest Developments
Table 99. GlaxoSmithKline plc Basic Information, Immunology Drug Manufacturing Base, Sales Area and Its Competitors
Table 100. GlaxoSmithKline plc Immunology Drug Product Portfolios and Specifications
Table 101. GlaxoSmithKline plc Immunology Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. GlaxoSmithKline plc Main Business
Table 103. GlaxoSmithKline plc Latest Developments
Table 104. Seattle Genetics Basic Information, Immunology Drug Manufacturing Base, Sales Area and Its Competitors
Table 105. Seattle Genetics Immunology Drug Product Portfolios and Specifications
Table 106. Seattle Genetics Immunology Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Seattle Genetics Main Business
Table 108. Seattle Genetics Latest Developments
Table 109. Genentech Basic Information, Immunology Drug Manufacturing Base, Sales Area and Its Competitors
Table 110. Genentech Immunology Drug Product Portfolios and Specifications
Table 111. Genentech Immunology Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Genentech Main Business
Table 113. Genentech Latest Developments
Table 114. F. Hoffmann-La Roche Ltd. Basic Information, Immunology Drug Manufacturing Base, Sales Area and Its Competitors
Table 115. F. Hoffmann-La Roche Ltd. Immunology Drug Product Portfolios and Specifications
Table 116. F. Hoffmann-La Roche Ltd. Immunology Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. F. Hoffmann-La Roche Ltd. Main Business
Table 118. F. Hoffmann-La Roche Ltd. Latest Developments
Table 119. Eisai Co. Basic Information, Immunology Drug Manufacturing Base, Sales Area and Its Competitors
Table 120. Eisai Co. Immunology Drug Product Portfolios and Specifications
Table 121. Eisai Co. Immunology Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Eisai Co. Main Business
Table 123. Eisai Co. Latest Developments
Table 124. Bayer AG Basic Information, Immunology Drug Manufacturing Base, Sales Area and Its Competitors
Table 125. Bayer AG Immunology Drug Product Portfolios and Specifications
Table 126. Bayer AG Immunology Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Bayer AG Main Business
Table 128. Bayer AG Latest Developments
Table 129. Sanofi Aventis LLC. Basic Information, Immunology Drug Manufacturing Base, Sales Area and Its Competitors
Table 130. Sanofi Aventis LLC. Immunology Drug Product Portfolios and Specifications
Table 131. Sanofi Aventis LLC. Immunology Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Sanofi Aventis LLC. Main Business
Table 133. Sanofi Aventis LLC. Latest Developments
LIST OF FIGURES
Figure 1. Picture of Immunology Drug
Figure 2. Immunology Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Immunology Drug Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Immunology Drug Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Immunology Drug Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Immunology Drug Sales Market Share by Country/Region (2024)
Figure 10. Immunology Drug Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Monoclonal Antibodies (mAb)
Figure 12. Product Picture of Antibody Drug Conjugates
Figure 13. Product Picture of Immunosuppressive medication
Figure 14. Product Picture of Others
Figure 15. Global Immunology Drug Sales Market Share by Type in 2025
Figure 16. Global Immunology Drug Revenue Market Share by Type (2020-2025)
Figure 17. Immunology Drug Consumed in Hospitals
Figure 18. Global Immunology Drug Market: Hospitals (2020-2025) & (K Units)
Figure 19. Immunology Drug Consumed in Clinics
Figure 20. Global Immunology Drug Market: Clinics (2020-2025) & (K Units)
Figure 21. Immunology Drug Consumed in Cancer Research Centers and Institutes
Figure 22. Global Immunology Drug Market: Cancer Research Centers and Institutes (2020-2025) & (K Units)
Figure 23. Global Immunology Drug Sale Market Share by Application (2024)
Figure 24. Global Immunology Drug Revenue Market Share by Application in 2025
Figure 25. Immunology Drug Sales by Company in 2025 (K Units)
Figure 26. Global Immunology Drug Sales Market Share by Company in 2025
Figure 27. Immunology Drug Revenue by Company in 2025 ($ millions)
Figure 28. Global Immunology Drug Revenue Market Share by Company in 2025
Figure 29. Global Immunology Drug Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Immunology Drug Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Immunology Drug Sales 2020-2025 (K Units)
Figure 32. Americas Immunology Drug Revenue 2020-2025 ($ millions)
Figure 33. APAC Immunology Drug Sales 2020-2025 (K Units)
Figure 34. APAC Immunology Drug Revenue 2020-2025 ($ millions)
Figure 35. Europe Immunology Drug Sales 2020-2025 (K Units)
Figure 36. Europe Immunology Drug Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Immunology Drug Sales 2020-2025 (K Units)
Figure 38. Middle East & Africa Immunology Drug Revenue 2020-2025 ($ millions)
Figure 39. Americas Immunology Drug Sales Market Share by Country in 2025
Figure 40. Americas Immunology Drug Revenue Market Share by Country (2020-2025)
Figure 41. Americas Immunology Drug Sales Market Share by Type (2020-2025)
Figure 42. Americas Immunology Drug Sales Market Share by Application (2020-2025)
Figure 43. United States Immunology Drug Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Immunology Drug Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Immunology Drug Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Immunology Drug Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Immunology Drug Sales Market Share by Region in 2025
Figure 48. APAC Immunology Drug Revenue Market Share by Region (2020-2025)
Figure 49. APAC Immunology Drug Sales Market Share by Type (2020-2025)
Figure 50. APAC Immunology Drug Sales Market Share by Application (2020-2025)
Figure 51. China Immunology Drug Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Immunology Drug Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Immunology Drug Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Immunology Drug Revenue Growth 2020-2025 ($ millions)
Figure 55. India Immunology Drug Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Immunology Drug Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan Immunology Drug Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Immunology Drug Sales Market Share by Country in 2025
Figure 59. Europe Immunology Drug Revenue Market Share by Country (2020-2025)
Figure 60. Europe Immunology Drug Sales Market Share by Type (2020-2025)
Figure 61. Europe Immunology Drug Sales Market Share by Application (2020-2025)
Figure 62. Germany Immunology Drug Revenue Growth 2020-2025 ($ millions)
Figure 63. France Immunology Drug Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Immunology Drug Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Immunology Drug Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Immunology Drug Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Immunology Drug Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Immunology Drug Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Immunology Drug Sales Market Share by Application (2020-2025)
Figure 70. Egypt Immunology Drug Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Immunology Drug Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Immunology Drug Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Immunology Drug Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Immunology Drug Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Immunology Drug in 2025
Figure 76. Manufacturing Process Analysis of Immunology Drug
Figure 77. Industry Chain Structure of Immunology Drug
Figure 78. Channels of Distribution
Figure 79. Global Immunology Drug Sales Market Forecast by Region (2026-2031)
Figure 80. Global Immunology Drug Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Immunology Drug Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Immunology Drug Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Immunology Drug Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global Immunology Drug Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Immunology Drug
Figure 2. Immunology Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Immunology Drug Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Immunology Drug Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Immunology Drug Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Immunology Drug Sales Market Share by Country/Region (2024)
Figure 10. Immunology Drug Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Monoclonal Antibodies (mAb)
Figure 12. Product Picture of Antibody Drug Conjugates
Figure 13. Product Picture of Immunosuppressive medication
Figure 14. Product Picture of Others
Figure 15. Global Immunology Drug Sales Market Share by Type in 2025
Figure 16. Global Immunology Drug Revenue Market Share by Type (2020-2025)
Figure 17. Immunology Drug Consumed in Hospitals
Figure 18. Global Immunology Drug Market: Hospitals (2020-2025) & (K Units)
Figure 19. Immunology Drug Consumed in Clinics
Figure 20. Global Immunology Drug Market: Clinics (2020-2025) & (K Units)
Figure 21. Immunology Drug Consumed in Cancer Research Centers and Institutes
Figure 22. Global Immunology Drug Market: Cancer Research Centers and Institutes (2020-2025) & (K Units)
Figure 23. Global Immunology Drug Sale Market Share by Application (2024)
Figure 24. Global Immunology Drug Revenue Market Share by Application in 2025
Figure 25. Immunology Drug Sales by Company in 2025 (K Units)
Figure 26. Global Immunology Drug Sales Market Share by Company in 2025
Figure 27. Immunology Drug Revenue by Company in 2025 ($ millions)
Figure 28. Global Immunology Drug Revenue Market Share by Company in 2025
Figure 29. Global Immunology Drug Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Immunology Drug Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Immunology Drug Sales 2020-2025 (K Units)
Figure 32. Americas Immunology Drug Revenue 2020-2025 ($ millions)
Figure 33. APAC Immunology Drug Sales 2020-2025 (K Units)
Figure 34. APAC Immunology Drug Revenue 2020-2025 ($ millions)
Figure 35. Europe Immunology Drug Sales 2020-2025 (K Units)
Figure 36. Europe Immunology Drug Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Immunology Drug Sales 2020-2025 (K Units)
Figure 38. Middle East & Africa Immunology Drug Revenue 2020-2025 ($ millions)
Figure 39. Americas Immunology Drug Sales Market Share by Country in 2025
Figure 40. Americas Immunology Drug Revenue Market Share by Country (2020-2025)
Figure 41. Americas Immunology Drug Sales Market Share by Type (2020-2025)
Figure 42. Americas Immunology Drug Sales Market Share by Application (2020-2025)
Figure 43. United States Immunology Drug Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Immunology Drug Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Immunology Drug Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Immunology Drug Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Immunology Drug Sales Market Share by Region in 2025
Figure 48. APAC Immunology Drug Revenue Market Share by Region (2020-2025)
Figure 49. APAC Immunology Drug Sales Market Share by Type (2020-2025)
Figure 50. APAC Immunology Drug Sales Market Share by Application (2020-2025)
Figure 51. China Immunology Drug Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Immunology Drug Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Immunology Drug Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Immunology Drug Revenue Growth 2020-2025 ($ millions)
Figure 55. India Immunology Drug Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Immunology Drug Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan Immunology Drug Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Immunology Drug Sales Market Share by Country in 2025
Figure 59. Europe Immunology Drug Revenue Market Share by Country (2020-2025)
Figure 60. Europe Immunology Drug Sales Market Share by Type (2020-2025)
Figure 61. Europe Immunology Drug Sales Market Share by Application (2020-2025)
Figure 62. Germany Immunology Drug Revenue Growth 2020-2025 ($ millions)
Figure 63. France Immunology Drug Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Immunology Drug Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Immunology Drug Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Immunology Drug Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Immunology Drug Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Immunology Drug Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Immunology Drug Sales Market Share by Application (2020-2025)
Figure 70. Egypt Immunology Drug Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Immunology Drug Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Immunology Drug Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Immunology Drug Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Immunology Drug Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Immunology Drug in 2025
Figure 76. Manufacturing Process Analysis of Immunology Drug
Figure 77. Industry Chain Structure of Immunology Drug
Figure 78. Channels of Distribution
Figure 79. Global Immunology Drug Sales Market Forecast by Region (2026-2031)
Figure 80. Global Immunology Drug Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Immunology Drug Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Immunology Drug Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Immunology Drug Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global Immunology Drug Revenue Market Share Forecast by Application (2026-2031)
